drugset / Trial / NCT04610827

Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder

NCT04610827

Phase 4 Terminated 6 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research study is to see if the level of serum ferritin differs based on how often oral iron (in the form of ferrous sulfate) is given to children with restless leg syndrome/periodic limb movement disorder.

Timeline

Start
2020-11-16
Primary completion
2021-06-29
Completion
2021-06-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Sulfate Diagnostic / imaging agent 1.5 mg/kg Oral
Comparator Ferrous Sulfate Diagnostic / imaging agent 3 mg/kg Oral
Comparator Ferrous Sulfate Diagnostic / imaging agent 6 mg/kg Oral